COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,351 Articles (22,803 medRxiv, 8,548 bioRxiv)

Most recent first Previous |  Page 3079: Articles 30781-30790  | Next

Master Regulator Analysis of the SARS-CoV-2/Human interactome
Guzzi, P. H., Mercatelli, D., Ceraolo, C., Giorgi, F. M.
10.1101/2020.03.15.992925 — Posted: 2020-03-17
Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection
Sacar Demirci, M. D., Adan, A.
10.1101/2020.03.15.992438 — Posted: 2020-03-17
The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
Procko, E.
10.1101/2020.03.16.994236 — Posted: 2020-03-17 Discussion: Onsite
Evidence of the Recombinant Origin and Ongoing Mutations in Severe Acute Respiratory Syndrome 2 (SARS-COV-2)
Huang, J.-M., Jan, S. S., Wei, X., Wan, Y., Ouyang, S.
10.1101/2020.03.16.993816 — Posted: 2020-03-17
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
Joyce, M. G., Sankhala, R. S., Chen, W.-H., Choe, M., Bai, H., Hajduczki, A., Yan, L., Sterling, S. L., Peterson, C., Green, E. C., Smith, C., de Val, N., Amare, M., Scott, P., Laing, E. D., Broder, C. C., Rolland, M., Michael, N. L., Modjarrad, K.
10.1101/2020.03.15.992883 — Posted: 2020-03-17
Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target
Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H., Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., Yang, X., Li, J., Yang, H., Liu, Z., Xu, W., Guddat, L. W., Wang, Q., Lou, Z., Rao, Z.
10.1101/2020.03.16.993386 — Posted: 2020-03-17 Discussion: Onsite | Offsite
An emergent clade of SARS-CoV-2 linked to returned travellers from Iran
Eden, J.-S., Rockett, R., Carter, I., Rahman, H., de Ligt, J., Hadfield, J., Storey, M., Ren, X., Tulloch, R., Basile, K., Wells, J., Byun, R., Gliroy, N., O'Sullivan, M. V., Sintchenko, V., Chen, S. C., Maddocks, S., Sorrell, T. C., Holmes, E. C., Dwyer, D. E., Kok, J.
10.1101/2020.03.15.992818 — Posted: 2020-03-17
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
Lv, H., Wu, N. C., Tsang, O. T.-Y., Yuan, M., Perera, R. A. P. M., Leung, W. S., So, R. T. Y., Chan, J. M. C., Yip, G. K., Chik, T. S. H., Wang, Y., Choi, C. Y. C., Lin, Y., Ng, W. W., Zhao, J., Poon, L. L. M., Peiris, J. S. M., Wilson, I. A., Mok, C. K. P.
10.1101/2020.03.15.993097 — Posted: 2020-03-17 Discussion: Onsite
Characterization of the SARS-CoV-2 Spike in an Early Prefusion Conformation
Li, S.
10.1101/2020.03.16.994152 — Posted: 2020-03-17
RBD mutations from circulating SARS-CoV-2 strains enhance the structure stability and infectivity of the spike protein
Ou, J., Zhou, Z., Zhang, J., Lan, W., Zhao, S., Wu, J., Seto, D., Zhang, G., Zhang, Q.
10.1101/2020.03.15.991844 — Posted: 2020-03-17 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).